Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

2:13FILE-TheburnedremainsofahomedestroyedbytheMarshallFireareshown,Jan.7,2022,inLouisville,Colo.OnTh FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida




hotspot

author：hotspot    Page View：742
Adam's take main illustration
Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

advertisement

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： FDA approves Recor Medical high blood pressure device
Next article： Psychedelics group wrestles with new pharma identity